ã¢ãã¡ãã¸ã§ã¸ã§ã®å¥å¦ãªåéº ã¹ãã¼ã³ãªã¼ã·ã£ã³ãWEBã©ã¸ãªãã¹ã¿ã¼ãï¼ï¼ãã¼ã½ããªãã£ã«ç©ºæ¡å¾å«å½¹ã®ãã¡ã¤ã«ã¼ãºãããããè¿ãã¦ãæ¯é±ãã¸ã§ã¸ã§ã®å¥å¦ãªåéº ã¹ãã¼ã³ãªã¼ã·ã£ã³ãã®ã話ããå±ããã¾ãã çªçµåï¼ãã¸ã§ã¸ã§ã®å¥å¦ãªåéº ã¹ãã¼ã³ãªã¼ã·ã£ã³ããªã©ãªã©ã¸ãªï¼³ ãã¼ã½ããªãã£ï¼ãã¡ã¤ã«ã¼ãºãã(空æ¡å¾å« å½¹) é ä¿¡éå§æ¥ï¼1æ6æ¥ããæ¯é±æ¨ææ¥æ´æ°äºå® é ä¿¡ãã©ãããã©ã¼ã ï¼Warner Bros. Japan Animeå ¬å¼YouTubeãã£ã³ãã«ãã¤ã³ã¿ã¼ãããã©ã¸ãªã¹ãã¼ã·ã§ã³ï¼é³æ³ï¼ ãã¡ã¼ã«åéã³ã¼ãã¼ã ãªã¹ãã¼ã®çãã¾ããã®ã便ããåéãããã¾ãã ä¸è¨ã®æ稿ãã©ã¼ã ããããã¯ã¡ã¼ã«ã¢ãã¬ã¹å®ã«ãéããã ããï¼ï¼ çªçµã®ã¡ã¼ã«æ稿ãã©ã¼ã ï¼https://www.onsen.ag/program/jojo/email_post?corner_id=967
ã¨ããNBERè«æãä¸ãã£ã¦ãããåé¡ã¯ãUsing Donald Trumpâs COVID-19 Vaccine Endorsement to Give Public Health a Shot in the Arm: A Large-Scale Ad Experimentãã§ãèè ã¯Bradley Larsenï¼ã¹ã¿ã³ãã©ã¼ã大ï¼ãMarc J. Hetheringtonï¼ãã¼ã¹ã«ãã©ã¤ã大ï¼ãSteven H. Greeneï¼ãã¼ã¹ã«ãã©ã¤ãå·ç«å¤§ï¼ãTimothy J. Ryanï¼ãã¼ã¹ã«ãã©ã¤ã大ï¼ãRahsaan D. Maxwellï¼åï¼ãSteven Tadelisï¼UCãã¼ã¯ã¬ã¼ï¼ã 以ä¸ã¯ãã®è¦æ¨ã We report a large-scale randomized controlled trial designed to assess whether the pa
ï¼æï¼ï¼æ¥ãå½éé貨åºéï¼ï¼©ï¼ï¼¦ï¼é«å®ã¯ãæè¿ã®åå®ã¯ãã¡ã³ãã¡ã³ã¿ã«ãºï¼çµæ¸ã®åºç¤çæ¡ä»¶ï¼ä¸»å°ã§ãããæ¥éã®è¶ ä½éå©æ¿çãå«ãæ¥æ¬ã®çµæ¸æ¿çãå¤æ´ããçç±ã«ã¯ãªããªãã¨ã®è¦è§£ã示ãããç±³é¦é½ã¯ã·ã³ãã³ã§ï¼ï¼ï¼ï¼å¹´ï¼ï¼ææ®å½±ï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼/Yuri Gripasï¼ ï¼»æ±äº¬ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - å½éé貨åºéï¼ï¼©ï¼ï¼¦ï¼é«å®ã¯ï¼ï¼æ¥ãæè¿ã®åå®ã¯ãã¡ã³ãã¡ã³ã¿ã«ãºï¼çµæ¸ã®åºç¤çæ¡ä»¶ï¼ä¸»å°ã§ãããæ¥éã®è¶ ä½éå©æ¿çãå«ãæ¥æ¬ã®çµæ¸æ¿çãå¤æ´ããçç±ã«ã¯ãªããªãã¨ã®è¦è§£ã示ããã Iï¼ï¼¦ã¢ã¸ã¢å¤ªå¹³æ´å±ã®ãµã³ã¸ã£ã¤ã»ãã³ã¹å¯å±é·ã¯ãã¤ã¿ã¼ã®ã¤ã³ã¿ãã¥ã¼ã§ãåç¸å ´ã§ããã¾ã§ã«è¦ããã¦ããã®ã¯ãã¡ã³ãã¡ã³ã¿ã«ãºä¸»å°ã ãã¨ãããçµæ¸æ¿çç«æ¡ã¯å¼ãç¶ããã¡ã³ãã¡ã³ã¿ã«ãºã«ç®ãåããã¹ãã ãç¾å¨ã®ååã¯ãã¡ã³ãã¡ã³ã¿ã«ãºãåæ ãã¦ãããçµæ¸æ¿çãå¤æ´ããçç±ã¯è¦å½ãããªããã¨è¿°ã¹ãã
åè ãè¾ãã¾ã Episode 02ãææ¥ã®èªåã楽ã«ãªãä»äºãããã [ã¢ãã¡] åç»ä¸è¦§ã¯ãã¡ãéçè»ã«ä»®æ¡ç¨ãããåè ã¬ãªãæ£è¦æ¡ç¨ã®ããã«ã¯ãæ£ä½ãé ãã¤ã¤éçè»å¾©èã«...
ï¼åéã»æ¦å½å²ç 究家ï¼è¥¿è¡ ç·çï¼ éåå¹åºæç«ãèªãä¸ã§æ¬ ãããªãäººç© ãéå殿ã®13人ãã®ç¬¬1åãã覧ã«ãªãã¾ãããï¼ æ¨å¹´ãå½ãµã¤ãã§ãéå殿ã¸ã®éããé£è¼ããã¦ããã ããç§ï¼è¥¿è¡ç·çï¼ã¯ããã®ãã©ãã«ä¸ä¸è»äºè証ã¨ããç«å ´ã§é¢ãããã¦ããã ãã¦ããã¾ãã主ã«ãæ¦ããæ¦å¨ã«ã¤ãã¦ã®ã¢ããã¤ã¶ã¼ã§ãããããã§ããã£ããã®ãç¸ã§ãã®ã§ãå½ãµã¤ãã§ãçããã®ãã©ãéè³ããµãã¼ãã§ãããããªè§£èª¬ããé£è¼ãã¦ã¿ããã¨æãã¾ãã ã¾ãã¯ãç»å ´äººç©ããã©ãã®ç¬¬1åã¯ãåæ¡ææ¿ã®å±æ·ã§ã«ãããã«ç¹°ãã²ãããããå®´ä¼ãä¸å¿ã§ãããè¿é£ã®æ¦å£«ãã¡ã大å¢éã¾ããå±æ·ã®é ã§ã¯éãã¦ããé ¼æãããã£ã¦ãè¥è ãã¡ãä¸é¨åãå½¼ãã®éã«ã¯ãä½ããè¤éãªäººéé¢ä¿ããå©å®³é¢ä¿ããããããã§ãã ä»åã®ç»å ´äººç©ãã¡ã®ãã¡ãæºé ¼æã»åæ¡ææ¿ã»ç¾©æã»æ¿åãããã¯ãçããããåãã¨æãã¾ããã§ã¯ãä»ã®äººãã¡ã¯ï¼ãå®ã¯ãä»åç»å ´
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}